Agilent Technologies, Inc. (NYSE: A) announced on Tuesday that Philip Binns has been appointed as president of the company's Life Sciences and Applied Markets Group (LSAG). Binns, who previously served as vice president and general manager of the Spectroscopy and Vacuum Solutions Division for LSAG, is taking over from Jacob Thaysen, who left the company the same day.
"We're extremely pleased to have someone with Phil's knowledge, experience and proven leadership strengths heading up our LSAG business," said Mike McMullen, Agilent president and CEO, to Business Wire. He expressed confidence in Binns' ability to drive continued success for LSAG and Agilent.
Binns joined Agilent in 2010 following the company's acquisition of Varian, Inc. His strategic vision and focus on execution have been instrumental in transforming Agilent's spectroscopy business into a market leader. Recognized for his exceptional leadership skills and deep market knowledge, Binns has assumed increasing levels of responsibility during his tenure at both Agilent and Varian.
Agilent Technologies Inc (NYSE:A). is a global leader in analytical and clinical laboratory technologies. The company offers a comprehensive range of solutions that include instruments, software, services, and expertise to help customers address their most challenging scientific questions. In fiscal 2022, the company generated revenue of $6.85 billion and currently employs 18,000 people worldwide.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.